Back to search
Skin Kaposi Sarcoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Kaposi Sarcoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Skin Kaposi Sarcoma trials you may qualify forThis phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of th…
Participants of this study will have a diagnosis of a solid tumor cancer that has come back to its original location or spread beyond its original location (adv…
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplas…
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplas…
This phase II trial studies how well low dose, reduced frequency nivolumab works in treating patients with cancer that cannot be removed by surgery (unresectabl…
This phase II trial studies how well nirogacestat works in treating patients with skin Kaposi sarcoma (KS). Several anti-cancer drugs work well in treating KS,…
This phase II clinical trial studies the side effects of pomalidomide and how well it works in treating patients with Kaposi sarcoma and human immunodeficiency…